SUBLOCADE Long-term Outcomes
Opioid Use DisorderThis study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
Participants must meet all of the following criteria:
* Is an adult ≥ 18 years of age who has signed the informed consent form
* Plans to receive additional SUBLOCADE injections and
* Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
* OR
* Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
* Is not currently participating in any clinical trial requiring medical intervention
* Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
Study Location
Brightshores Health System
Brightshores Health SystemOwen Sound, Ontario
Canada
Contact Study Team
Robyn Nocilla, NP
The Stipley Clinic
The Stipley ClinicHamilton, Ontario
Canada
Contact Study Team
Leonora Regenstreif, MD
Smart Clinic
Smart ClinicCalgary, Alberta
Canada
Contact Study Team
Navneet Khosa, MD
Bluewater Rapid Assessment Addiction Medicine Clinic
Bluewater Rapid Assessment Addiction Medicine ClinicSarnia, Ontario
Canada
Contact Study Team
Delmar Donald, MD
Savera Medical Centre
Savera Medical CentreEdmonton, Ontario
Canada
Contact Study Team
Comprehensive Treatment Clinic
Comprehensive Treatment ClinicToronto, Ontario
Canada
Contact Study Team
Leonard Bienenstock, MD
- Study Sponsored By
- Indivior Inc.
- Participants Required
- More Information
- Study ID:
NCT05860959